Trial NCT00089778

View at ClinicalTrials.gov 
Aliases: NCT00091403
Org. Study IDs: 040259
Secondary IDs: 04-C-0259

Last trial update was posted on 2017-08-01

MeSH Interventions

Aldesleukin Interleukin-2 Mitogens

MeSH Conditions

Carcinoma, Renal Cell Kidney Neoplasms

Other Conditions

Kidney Cancer

Stopping Reasons

fewer tumors than expected expressed FGF-5, led to end of accrual to cohorts A&B

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID